BioSpace News Archive

The importance of this solution is driven by deep concern among employers regarding the skyrocketing costs of their prescription drug plans, particularly specialty drugs.

Amerigen Pharmaceuticals Limited and Inventia Healthcare Limited announced they had entered into a collaboration involving two of Inventia’s recently approved U.S. ANDA’s.

PureTech Health plc (LSE: PRTC) (“PureTech”), a clinical stage biotechnology company dedicated to discovering, developing and commercialising highly differentiated medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, is pleased to note that its affiliate, Vedanta Biosciences, added $16.6 million to its Series C financing round, bringing the total capital raised to $62.1 million.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research [23-September-2019] SAN ANTONIO , Sept. 23, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by

Biovo Technologies Ltd. (“Biovo”), a medical device company focusing on Critical Care and Operating Rooms, announced today it will launch its novel HyperForm™ product line at The American Association for Respiratory care (AARC) conference in New Orleans, which will take place during November 9th-12th.

The South Carolina Hospital Association is pleased to announce that we have recognized a record-breaking 57 SC hospitals who collectively won 230 Certified Zero Harm Awards this year.

GenSight Biologics, a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported the first set of results from Week 96 of the RESCUE Phase III clinical trial.

Merck KGaA, Darmstadt, Germany announced that new data representing several key therapeutic agents from its diverse oncology pipeline will be presented at the 2019 European Society for Medical Oncology Congress, September 27–October 1, in Barcelona, Spain.

4D pharma announces the publication of data highlighting the neuroprotective properties of MRx0005 and MRx0029

AbbVie announced experts in the neuroscience field will present results from two late-breaking abstracts, including final data from the Phase 1b study evaluating the safety and tolerability of the investigational medicine ABBV-951 in patients with advanced Parkinson’s disease (PD), and data from the real-world DUOGLOBE study, evaluating the effect of DUODOPA® in patients with advanced Parkinson’s disease.